Description
The National Institutes of Health (NIH) NIAID’s Viral Pathogenesis and Evolution Section (VPES) intends to award a firm‑fixed‑price, single‑source contract to Genedata (USA), Inc. for a one‑year renewal of the Genedata Analyst bioinformatics software. The software supports multi‑omics data analysis—including genomics, transcriptomics, and proteomics—through data normalization, statistical modeling, machine‑learning, and interactive visualizations. Continuity of the existing analytical environment is critical because VPES holds over 100 million gene‑expression data points from eight years of vaccine and infection studies. Replacing the tool would require costly data migration, workflow redevelopment, and user retraining, potentially disrupting ongoing research into universal influenza vaccines and other viral pathogens.
• Firm‑fixed‑price, 12‑month renewal of Genedata Analyst software
• Supports statistical modeling, machine learning, and visualization of multi‑omics data
• Critical for continuity of VPES research on vaccine development and viral pathogenesis
• Single‑source justification: only Genedata provides the required functionality and historical data compatibility
• Capability statements accepted until September 14 2026 (1:00 PM ET) to determine if a competitive procurement will be pursued.